Dr. Gongxin He is a distinguished pharmaceutical scientist and entrepreneur with a career spanning over three decades in innovative drug research and development. He earned his PhD in Synthetic Chemistry from Kyushu University (Japan) in 1988 and conducted his postdoctoral research at the University of California, Santa Barbara.<br>Dr. He's most notable contribution came during his career at Gilead Sciences (1992-2018), where he was the principal inventor and project leader for tenofovir alafenamide (TAF).

Sarah Voytek is a drug developer with more than 15 years of experience working in preclinical and translational development at biotech and large pharma companies in Boston. She obtained her PhD from The Scripps Research Institute, where she researched in vitro evolution of catalytic RNAs, and her BS from Brown University. <br>Sarah started her career at Novartis, working in Discovery and Investigative Safety, where she led a laboratory studying pharmacologic & toxicologic drug mechanisms and served as a preclinical safety lead.

Clayton Ade-Andrew Ruley is currently the Director of Diversity, Equity, Inclusion and Harm Reduction at the Community Liver Alliance (CLA).

Chris is our Volunteer Coordinator and a seasoned healthcare reimbursement professional with over 30 years of experience, including the past 15 years dedicated to community health and community mental health centers.<br>She enjoys supporting uninsured and underinsured populations. She is a newly certified SHIP (State Health Insurance Assistance Program) Counselor in Indiana, where she assists Medicare-eligible individuals in navigating the complex enrollment process and helps them understand their coverage options.

L. Marie Asad is a patient advocate, community engagement leader and currently services as President of the Friends of the PBC Foundation, NFP., an a transformative organization dedicated to serving those affected by Primary Biliary Cholangitis (PBC), in the United States. Ms. Asad, holds a Master of Arts degree in Gerontology from Concordia University, a Leadership Certificate from the Organizational Leadership Institute and Bachelor of Art degree from Illinois State University.

Esther Caparrós holds a PhD in Biological Sciences and is a Professor of Immunology at Miguel Hernández University in Alicante. She is a member of the Hepatic and Intestinal Immunobiology Group, where she studies the interaction between the immune response and the translocation of bacterial products in chronic inflammatory liver and intestinal diseases. She investigates the molecular and cellular aspects of the immune system responsible for surveillance, response, and regulation of homeostasis in the liver-intestine axis.

Jim is a Professor at MSU and his research program focuses on blood coagulation and liver disease

Dr. Monga is the SVC Endowed Chair in Pathobiology and Therapeutics and Professor of Pharmacology and Medicine at the University of Pittsburgh. He is the Chair/Director of the Organ Pathobiology and Therapeutics Institute. He is also the director of the Pittsburgh Liver Research Center, an NIDDK P30 funded Digestive Disease Research Core Center and the program director of the Cellular Approaches to Tissue Engineering and Regeneration, NIBIB T32 funded predoctoral training program. He serves as the Associate Dean of Research for the University of Pittsburgh School of Medicine.